Neimeth Shareholder Clinoscope Sells 515m Shares in Major Disposal

Clinoscope Services Limited, a substantial shareholder of Neimeth International Pharmaceuticals Plc, has disposed of a significant stake in the company, selling a total of 515.3 million ordinary shares, according to a regulatory filing with the Nigerian Exchange Limited (NGX).

The transactions, conducted in Lagos between September 17 and December 19, 2025, involved the sale of Neimeth shares with ISIN NGNEIMETH001. Details of the filing reveal that 15.3 million shares were sold at N6.10 per share, while a larger block of 500 million shares was disposed of at N6.00 per share. The aggregate volume of shares sold stood at 515.3 million units, translating to an average price of N6.05 per share.

Clinoscope Services Limited was identified in the notification as a substantial shareholder of Neimeth International Pharmaceuticals Plc. The transaction was classified as an initial notification, aligning with market disclosure requirements aimed at maintaining transparency and investor awareness.

Neimeth International Pharmaceuticals Plc, a listed healthcare company, notified the Exchange of the insider dealing in compliance with post-trade transparency and corporate governance rules.

The company emphasized that the notification relates solely to the share sale by the shareholder and does not impact its day-to-day operations.

The disposal represents a significant movement in the company’s shareholder structure, with implications for market observers and investors tracking the performance of Neimeth International Pharmaceuticals Plc on the Nigerian Exchange.